Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

Pallas Health Review

Online GLP-1 and NAD+ care with bundled provider support, a $139 compounded-semaglutide first month, and a dedicated NAD+ program.

Last reviewed August 2026
3 studies cited
Fact-checked 15 August 2026Last updated 15 August 2026From $139 – $299/moEditor Score 4.1 / 5

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Online GLP-1 and NAD+ care with bundled provider support, a $139 compounded-semaglutide first month, and a dedicated NAD+ program.

Who it's for: Pallas Health suits adults who want online GLP-1 care with clinician review, ongoing care-team support and a single published price that includes provider care, messaging and shipping. Its weight-loss program lists both FDA-approved branded GLP-1s and compounded semaglutide or tirzepatide when a clinician determines treatment is appropriate. The first-month compounded prices are relatively clear: $139 for semaglutide and $179 for tirzepatide. The important renewal detail is that subsequent compounded refills are billed every 12 weeks, equivalent to $199/mo and $299/mo on average, respectively. Pallas also offers clinician-prescribed NAD+ nasal spray and injection programs, making it a broader option than a GLP-1-only clinic. It is less suitable for patients who want insurance billing or a simple ongoing one-month refill structure after the introductory period.

Bottom line: Pallas Health combines a polished bundled-care GLP-1 program with an uncommon NAD+ offering. It earns credit for stating its introductory and renewal pricing clearly, including the 12-week renewal cadence, and for listing both compounded and FDA-approved options. The headline introductory rate is not the long-term average, however, and the program is private pay. Consider Pallas if you value ongoing provider support, free shipping and the option to explore NAD+ alongside weight management; confirm the exact medication, quarterly renewal amount and state-specific visit requirements before enrolling.

Pros
  • Provider care, messaging, shipping and dose adjustments included in the published plan price
  • Compounded semaglutide first month from $139 and tirzepatide from $179
  • Lists both compounded and FDA-approved GLP-1 options
  • Dedicated NAD+ nasal-spray and injection program
Cons
  • Compounded-program renewals are billed in 12-week intervals after the first month
  • Private pay; insurance is not billed
  • Compounded medications are not FDA-approved finished drugs
  • Limited independent review history assessed for this initial review

Pros & Cons In Detail

Provider care, messaging, shipping and dose adjustments included in the published plan price
Reliable shipping is the most underrated quality signal in telehealth. patients who switch providers usually do so because of refill timing, not price.
Compounded semaglutide first month from $139 and tirzepatide from $179
In practice this is one of the differentiators that pushes Pallas Health's editor score above the category median.
Lists both compounded and FDA-approved GLP-1 options
Carrying both compounded and FDA-approved options gives Pallas Health more flexibility if a patient needs to switch tracks for insurance, supply, or efficacy reasons mid-program.
Dedicated NAD+ nasal-spray and injection program
In practice this is one of the differentiators that pushes Pallas Health's editor score above the category median.
Compounded-program renewals are billed in 12-week intervals after the first month
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Private pay; insurance is not billed
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Compounded medications are not FDA-approved finished drugs
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Limited independent review history assessed for this initial review
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Pallas Health Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Pallas Health.

Program / Membership FeeIncluded in plan price
Medication Cost (From)From $139 – $299/mo
What This Means For You

Pallas advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks ($199/mo average), and compounded tirzepatide at $179 for the first month, then $897 every 12 weeks ($299/mo average). Prices include provider care; confirm the renewal charge and medication selection during intake.

Who Pallas Health Is For

Pallas Health suits adults who want online GLP-1 care with clinician review, ongoing care-team support and a single published price that includes provider care, messaging and shipping. Its weight-loss program lists both FDA-approved branded GLP-1s and compounded semaglutide or tirzepatide when a clinician determines treatment is appropriate. The first-month compounded prices are relatively clear: $139 for semaglutide and $179 for tirzepatide. The important renewal detail is that subsequent compounded refills are billed every 12 weeks, equivalent to $199/mo and $299/mo on average, respectively. Pallas also offers clinician-prescribed NAD+ nasal spray and injection programs, making it a broader option than a GLP-1-only clinic. It is less suitable for patients who want insurance billing or a simple ongoing one-month refill structure after the introductory period.

How Pallas Health Markets Itself

Adults seeking online GLP-1 care with clinician review, bundled provider support and brand-name or compounded options when clinically appropriate.

Signature Programs

  • ›Compounded semaglutide and tirzepatide plans
  • ›FDA-approved Wegovy, Zepbound, Ozempic and Mounjaro options
  • ›NAD+ nasal spray and injection programs
  • ›Provider care, check-ins and shipping included

Medication Formulary

FDA-Approved Access
WegovyZepboundOzempicMounjaro
Full Formulary
compounded semaglutidecompounded tirzepatideWegovyZepboundOzempicMounjaronad+ nasal spraynad+ injection

The Bottom Line

Pallas Health combines a polished bundled-care GLP-1 program with an uncommon NAD+ offering. It earns credit for stating its introductory and renewal pricing clearly, including the 12-week renewal cadence, and for listing both compounded and FDA-approved options. The headline introductory rate is not the long-term average, however, and the program is private pay. Consider Pallas if you value ongoing provider support, free shipping and the option to explore NAD+ alongside weight management; confirm the exact medication, quarterly renewal amount and state-specific visit requirements before enrolling.

With an editor score of 4.1 / 5 across cost, experience, and trust, Pallas Health is one of the specialty options in the glp-1 weight loss category we cover.

See how Pallas Health compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss versus 2.4% with placebo at 68 weeks in the STEP 1 trial.
  2. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss versus 3.1% with placebo at 72 weeks in SURMOUNT-1.
  3. Lincoff et al., NEJM 2023 (SELECT) · In adults with overweight or obesity and established cardiovascular disease, semaglutide 2.4 mg reduced major adverse cardiovascular events in the SELECT trial.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

Alternatives To Pallas Health

Also Competes With

Pallas Health also operates in Longevity & NAD+. Here are other providers in those spaces:

§ Continue Reading